Skinner, Kenneth A. https://orcid.org/0000-0001-6407-5034
Fisher, Troy D. https://orcid.org/0009-0006-1306-0397
Lee, Andrew https://orcid.org/0000-0002-7665-1999
Su, Taojunfeng https://orcid.org/0000-0002-7111-1248
Forte, Eleonora https://orcid.org/0000-0002-6095-2797
Sanchez, Aniel https://orcid.org/0000-0002-0278-8802
Caldwell, Michael A. https://orcid.org/0000-0002-8636-0706
Kelleher, Neil L. https://orcid.org/0000-0002-8815-3372
Funding for this research was provided by:
National Institute of General Medical Sciences (RM1 GM156535)
Article History
Received: 17 July 2025
Revised: 22 August 2025
Accepted: 26 August 2025
First Online: 1 October 2025
Declarations
:
: KAS is a shareholder and former employee of Quantum-Si. NLK serves as a consultant to Thermo Fisher Scientific and is engaged in various entrepreneurial activities related to TD-MS. The other authors declare no competing interests.